circRNA basic information
circBase ID: hsa_circ_0017274
Name: hsa_circ_HNRNPU
Synonym: circ_0017274
Host Gene: HNRNPU
Genomic location(hg19): chr1:245019758-245021576:-
Genomic location(hg38): chr1:244856456-244858274:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0001056
MONDO name: gastric cancer
Disease details: gastric cancer
Disease DO ID:
10534
Disease MeSH ID:
-
Disease NCIt ID:
C9331
Disease ICD11 ID:
1397617262
Disease OMIM ID:
613659
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumour tissues; corresponding paracancerous tissues; CDDP-resistant GC tissues; CDDP-sensitive GC tissues

Cell lines:

GES-1; HGC27; AGS; HGC27/CDDP; AGS/CDDP

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: CDX2, PCNA, Bax, E-cadherin, MRP1
Associated microRNA: miR-637
Biological function: Facilitates cisplatin resistance and gastric cancer progression; promotes cell viability, proliferation, migration and invasion; inhibits cell cycle arrest and apoptosis; knockdown enhances CDDP sensitivity and suppresses tumour growth in vivo.
Molecular mechanism: circ_0017274 functions as a miR-637 sponge and regulates the miR-637/CDX2 axis to promote CDDP resistance in gastric cancer.
Biological pathway or process:

ceRNA regulation (promotes); drug resistance (promotes); chemoresistance (promotes); proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); migration (promotes); invasion (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; EdU Staining; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; In Vivo Animal Model; IHC (Immunohistochemistry)

Clinical significance:

circ_0017274 could be involved in CDDP resistance in GC and could potentially be a molecular marker for GC diagnosis and a target for improving drug resistance.

Description:

circ_0017274 is up-regulated in cisplatin-resistant gastric cancer tissues and cells. It promotes CDDP resistance and malignant phenotypes by sponging miR-637 and regulating CDX2, while circ_0017274 knockdown enhances CDDP sensitivity, suppresses proliferation, migration and invasion, promotes apoptosis, and inhibits xenograft tumour growth.

Confidence score:

0.8325

Other information
Title:

Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.

Journal: Clinical and experimental pharmacology & physiology
Published: 2022
PubMed ID: 35748299
Study type:

combined biological and clinical study

Data availability: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability: -